Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rhabdomyosarcoma 1Neurofibrosarcoma 1Neoplasms, Connective and Soft Tissue 1Myosarcoma 1Microsatellite Instability 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Histiocytoma 1Glioma 1Glioblastoma 1Fibrosarcoma 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 81S 1 (combination) 55Capecitabine 44apatinib 32Paclitaxel 32Docetaxel 32Irinotecan 27Fluorouracil 22Drug Therapy 21sintilimab 20Cisplatin 20Leucovorin 16Hyperthermic Intraperitoneal Chemotherapy 13XELOX 12Surgical Procedures, Operative 12camrelizumab 10Trastuzumab 10titanium silicide 9pembrolizumab 9Tegafur 9Nivolumab 9Neoadjuvant Therapy 9Laparoscopy 8Gastrectomy 8Ramucirumab 7Folfox protocol 7Chemotherapy, Adjuvant 7toripalimab 6tislelizumab 6Gastroscopy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Stomach Neoplasms × lentiviral minigene vaccine of COVID-19 coronavirus × Clear all
NCT04567069 2020-09-28

Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment

The Second Hospital of Shandong University

Phase 1/2 Unknown
45 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡